1. Brierley S, Adams C, Suelter J, Gooch T, Becker B. Safety and tolerance of high-frequency chest wall oscillation (HFCWO) in hospitalized critical care patients. Respir Care 2003; 48 (11): 1112. (ABSTRACT) Note: Observational study of 73 critical care/post-surgical patients treated with HFCWO.
2. RespirTech Post Risk Review RAR10001v12
3. Nicolini A, Cardini F, Landucci N, Lanata S, Ferrari-Bravo M, Barlascini C. Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis. BMC Pulm Med. 2013;13:21. Note: 37 BE patient study comparing HFCC, OPEP or no-ACT.
4.Plioplys AV, Lewis S, Kasnicka I. Pulmonary vest therapy in pediatric long-term care. J Am Med Dir Assoc 2002;3:318-321. Note: Study of 7 quadriplegic cerebral palsy patients, 4 having epilepsy.
5. Lechtzin N, Wolfe LF, Frick KD. The Impact of High-Frequency Chest Wall Oscillation on Healthcare Use in Patients with Neuromuscular Diseases. Annals of the American Thoracic Society 2016;13(6):904-909. Note: 426 patients NMD patients.
6. Barto T, et al. Registry Outcomes for HFCWO Vest Therapy in Adult Patients with Bronchiectasis. Poster presented at: Am Thor Soc Intern Confer; 15 May 2016; San Francisco, Calif. Note: 2596 BE patient registry study comparing hospitalizations, antibiotic use and self-reported QOL metrics before and after HFCWO therapy.
7. Warwick WJ and Hansen LG Chest Compression Apparatus [Patent] : 6958046. – US, Oct. 25, 2005.
8. Giarraffa P, Berger KI, Chaikin AA, Axelrod FB, Davey C, Becker B. Assessing efficacy of high-frequency chest wall oscillation in patients with familial dysautonomia. CHEST 2005;128:3377-3381. Note: Year-long study of 15 patients with pulmonary disease due to Riley-Day syndrome.
9. Landon CG, W.; Evans, J. Airway Clearance Therapy Utilizing High-Frequency Chest Wall Oscillation for Medically Fragile Children. Poster Session at the Annual Meeting of the American Medical Directors Association, March 2002, San Francisco, CA 2002: (POSTER). Note: 15 patient study comparing pre/post HFCWO therapy use.
10. Plioplys AV, Lewis S, Kasnicka I. Pulmonary vest therapy in pediatric long-term care. J Am Med Dir Assoc 2002;3:318-321. Note: Study of 7 quadriplegic cerebral palsy patients, 4 having epilepsy.
11. Warwick WJ, Hansen LG. The long-term effect of high-frequency chest compression therapy on pulmonary complications of cystic fibrosis. Pediatr Pulmonal 1991; 11:265-271. Note: 16 CF patient study comparing pulmonary function following CPT to HFCC therapy.
12. Arens R, Gozal D, Omlin KJ, Vega J, Boyd KP, Keens TG, Woo MS. Comparison of high-frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. Am J Repir Crit Care Med 1994; 150: 1154-1157. Note: 50 CF patient study comparing conventional CPT to HFCC.
13. Milla CE, Hansen LG, Weber A, Warwick WJ. High-Frequency chest compression: effect of the third generation compression waveform. Biomed Instrum Technol 2004; 38:322-328. Note: 8 CF patient study comparing triangular vs. sine waveform technology.
14. Garstang SV, Kirshblum SC, Wood KE. “Patient preference for in-exsufflation for secretion management with spinal cord injury.” J Spinal Cord Med 2000;23(2)80-85.
15. Liszner K, et al. “CoughAssist Strategy for Pulmonary Toileting in Ventilator-Dependent Spinal Cord Injured Patients” Rehabilitation Nursing 2006;31:218-221.